Results 201 to 210 of about 4,071 (233)
Some of the next articles are maybe not open access.

Inadvertent Subconjunctival Injection of a Fluocinolone Acetonide Implant

JAMA Ophthalmology, 2019
Michael J, Venincasa, Jayanth, Sridhar
openaire   +2 more sources

[Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].

Journal francais d'ophtalmologie, 2016
Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy and may cause severe visual loss. In this article, we examine the pathophysiology of DME and review various treatment options, such as laser photocoagulation, anti-vascular endothelial growth factor (VEGF) receptor antibodies, and steroids including ILUVIEN(®), which is a ...
G, Soubrane, F, Behar-Cohen
openaire   +1 more source

Safety and efficacy profile of the fluocinolone acetonide implant in non-infectious uveitic macular edema: 5-year follow-up.

Archivos de la Sociedad Española de Oftalmología
N. Ruiz Del Rio   +5 more
semanticscholar   +1 more source

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the treatment of ocular juvenile xanthogranuloma.

Archivos de la Sociedad Española de Oftalmología
M. Larrañaga Cores   +6 more
semanticscholar   +1 more source

Fluocinolone acetonide implant recommended by NICE

PharmacoEconomics & Outcomes News, 2019
openaire   +1 more source

Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases

International Journal of Biological Macromolecules, 2020
Muhammad Uzair Hashmi   +2 more
exaly  

Single institution experience of intravitreal 0.18 mg fluocinolone acetonide implant for non-infectious uveitis.

Ophthalmology Retina, 2022
Amit K. Reddy   +3 more
semanticscholar   +1 more source

Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis

Ophthalmology, 2006
Glenn J. Jaffe   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy